Sorry, you need to enable JavaScript to visit this website.

Effective immediately, this office requires a referral with all insurance plans to schedule a new patient consultation.

Endocrine Associates Of Dallas, P.A.

Proudly Part of Privia Health

Effective immediately, this office requires a referral with all insurance plans to schedule a new patient consultation.

Elizabeth King, MD

Elizabeth King

Elizabeth King, MD

Accepts New Patients

Offers Virtual Visits

Make an Appointment

Location(s)

Dallas Office

10260 North Central Expressway
Suite 100N
Dallas, TX 75231

Accepts New Patients

Offers Virtual Visits

Occupation

ADULT ENDOCRINOLOGIST

* Requires Referral For New Patients *

Board Certification

American Board of Internal Medicine (ABIM)
Endocrinology, Diabetes, & Metabolism

Certifications

Certified Clinical Densitometrist, International Society for Clinical Densitometry

Education

Fellowship
The University of Texas Health Science Center
Endocrinology, Diabetes, and Metabolism
San Antonio, 2007-2009

Internship and Residency
The University of Texas Health Science Center
Internal Medicine

Medical School
University of Texas Medical School
San Antonio, 2003

Undergraduate School
University of Texas at Austin
Bachelor of Business Administration, Finance
Cum Laude, 1999

Current Positions

Endocrinologist, Endocrine Associates of Dallas 
Texas Health Presbyterian Hospitals, Dallas

Past Positions

2011-2014 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Southwestern Medical Center
2009-2011 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Health Science Center at San Antonio
2006-2011 Chief Resident/Clinical Instructor, Department of Medicine, The University of Texas Health Science Center at San Antonio

Professional Associations

Texas Medical Association
International Society for Clinical Densitometry

Licensure 
State of Texas

Publications

  1. Kadiyala S, Khan Y, de Miguel V, Frone MN, Nwariaku F, Rabaglia J, Woodruff S, King EE, Hathiramani SS, Pacak K, and Ghayee HK. SDHD mutation: looking beyond head and neck tumors. AACE Clinical Case Reports 2017. https://doi.org/10.4158/EP172003.CR
  2. King EE, Qin Y, Toledo RA, Luo A, Ball E, Faucz FR, Janeway KA, Stratakis CA, Tomlinson GE, Dahia PL.  Integrity of the pheochromocytoma susceptibility TMEM127 gene in patients with pediatric malignancies.  Endocrine Related Cancer 2015; 22(3): L5-7.
  3. Yao L, Schiavi F, Cascon A, Qin Y, Inglada-Perez L, King EE, Toledo RA, Ercolino T, Rapizzi E, Ricketts CJ, Mori L, Giacche M, Mendola A, Taschin E, Boaretto F, Loli P, Iacobone M, Rossi GP, Biondi B, Lima-Junior JV, Kater CE, Bex M, Vikkula M, Grossman AB, Gruber SB, Barontini M, Persu A, Castellano M, Toledo SPA, Maher ER, Mannelli M, Opocher G, Robledo M, Dahia PLM. Spectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas.  JAMA 2010; 304(23): 2611-2619.
  4. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SPA, Stiles C, Aguiar RCT, Dahia PLM. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.  Nature Genetics 2010; 42(3): 229-233.
  5. King EE, Dahia PLM.  Molecular biology of pheochromocytomas and paragangliomas In: Lloyd RV (ed).  Endocrine Pathology: Differential Diagnosis and Molecular Advances, 2nd Edition. New York: Springer: 2009. p. 297-305.
  6. King EE, King CA. Long white coat marks transition. San Antonio Medicine 2004; 57:32-34.

Abstracts/Presentations

  1. Hussein I, King EE, Mirfakhraee S. Mifepristone as a bridging therapy to gamma knife radiosurgery in recurrent Cushing’s disease. Abstract, Endocrine Society Meeting, San Diego, 2015.
  2. Basani S, King EE, Mirfakhraee S. Mifepristone for preoperative treatment of hypercortisolism from Cushing’s disease: a case report. Abstract, Endocrine Society Meeting, San Diego, 2015.
  3. DeGueme AM, King EE, Mirfakhraee S. Medical treatment of Cushing’s disease with mifepristone: a clinical case series. Abstract, Endocrine Society Meeting, San Diego, 2015.
  4. King EE and Howell SM. Clinical management in a female with persistent Cushing’s disease treated with mifepristone for four years.  Abstract, Endocrine Society Meeting, Chicago, 2014.
  5. King EE, Hashim IA, Auchus RJ, Xie XJ, Christie A, Castanon R, Brophey MD, Ghayee HK. Value of ACTH distinguishing pituitary versus ectopic causes of Cushing’s syndrome. Abstract, Endocrine Society Meeting, Chicago, 2014.
  6. Chokshi N, Maekawa T, Sasano H, Carrick K, Woodruff S, Rabaglia J, Nwariaku F, Ghayee HK, King EE. Benign Cortisol Producing Adrenal Adenomas Co-Secreting Salt or Sex Hormones. Abstract, Endocrine Society Meeting, San Francisco, 2013.
  7. Ghayee HK, Farley M, Nwariaku F, Woodruff S, Rabaglia J, King EE, Hathiramani S. Bilateral pheochromocytomas in a patient with SDHD mutation. Abstract, Endocrine Society Meeting, San Francisco, 2013.
  8. Shulman RM, Meyn S, Druker H, Malkin D, Gerstle TJ, Hwa V, Fofanova-Gambetti OV, Dahia P, Rosenfeld R, King EE, Hamilton J.  The short and the sweaty: a case of familial pheochromocytoma and growth hormone gene mutation. Abstract, Lawson Wilkins Pediatric Endocrine Society/European Society for Pediatric Endocrinology Meeting, New York, 2009.
  9. King E, Dahia P, Tischler A. The new putative pheochromocytoma/neuroblastoma susceptibility gene KIF1Bb is infrequently mutated in pheochromocytomas associated with other malignancies.  Abstract, Endocrine Society Meeting, Washington, D.C., 2009 AND Oral/Poster Presentation—12th Annual UTHSCSA Department of Medicine Research Day 2009.
  10. Bischoff B, King E, Simcic K, Crawford G.  Two cases of pheochromocytoma in males with NF1 presenting with adrenal incidentalomas. Abstract 15th Annual South Texas ACP Associates Program 2008 AND 11th Annual UTHSCSA Department of Medicine Research Day, San Antonio, Texas, 2008
  11. King E. Oral Case Presentation, Thyroid Function/Graves Disease,78th Annual Meeting of the American Thyroid Association, Fellows’ Track, New York, 2007
  12. King E, Perkins W. Rapid development of hepatic and splenic abscesses in a woman with hereditary hemorrhagic telangiectasia syndrome.  Abstract, 12th Annual South Texas ACP Associates Program 2005 AND 8th Annual Department of Medicine Research Day, San Antonio, Texas, 2005.
  13. Edrington (King) E, Bruder JM.  Effects of the hypogonadal state on lipid levels in patients treated for prostate cancer.  Abstract, 6th Annual Department of Medicine Research Day, San Antonio, Texas, 2003.    

Invited Lectures

  1. 2018      “Pituitary Incidentaloma: Evaluation and Management” Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
  2. 2016     “Polycystic Ovarian Syndrome: What Are the Problems and How Do We Solve Them?”, Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
  3. 2015     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” Texas AACE Meeting for Primary Care Providers, Austin, Texas
  4. 2015     “When Things Get Interesting: Cushing’s Outside the Pituitary,” Texas AACE Meeting, Austin, Texas
  5. 2014     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” Update in Internal Medicine Conference, UTSW, Dallas, Texas
  6. 2014     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
  7. 2014     “Cushing’s Syndrome: Diagnostic Challenges, Treatment Failures, and Hope for the Future,” UTSW Endocrinology Grand Rounds, Dallas, Texas
  8. 2013     “Pituitary and Adrenal Incidentalomas,” Update in Internal Medicine, UTSW, Dallas, Texas
  9. 2013     “Pheochromocytoma in 2013: What We Know and What We Need to Learn,” Texas Health Presbyterian Internal Medicine Grand Rounds, Dallas, Texas
  10. 2012     “Molecular Aspects of Pheochromocytoma: What We Know and What We Need to Learn,”, UTSW Endocrinology Grand Rounds, Dallas, Texas
  11. 2012     “Pheochromocytoma in 2012: Diagnosis and Management,” TexMed 2012, Texas Medical Association, Dallas, Texas
  12. 2011     “PCOS: A Review,” UTHSCSA Endocrinology Grand Rounds, San Antonio, Texas
  13. 2010     “Pheochromocytoma: An Update,” UTHSCSA Endocrinology Grand Rounds, San Antonio, Texas
  14. 2010     “The Adrenal Incidentaloma—Cushing’s, Pheo, Hyperaldo! Oh My!” UTHSCSA Internal Medicine Grand Rounds, San Antonio, Texas
  15. 2010     “Diagnosis and Management of Common Thyroid Disorders,” UTHSCSA School of Nursing Continuing Education, San Antonio, Texas
  16. 2009     “Cushing’s Syndrome,” UTHSCSA Endocrinology Grand Rounds, San Antonio, Texas
  17. 2009     “Diabetes and Lipids,” ACP Internal Medicine Board Review, San Antonio, Texas
  18. 2008     “Molecular Basis of Pheochromocytoma,” UTHSCSA Endocrinology Grand Rounds, San
  19. Antonio, Texas

Continuing Medical/Dental/Specialty Education Conferences and eConferences

  1. Endocrine Society Annual Meeting, Orlando, FL 2017
  2. Texas AACE/TESS Annual Meeting, Dallas, TX 2016
  3. Texas AACE/TESS Annual Meeting, Austin, TX 2015
  4. Endocrine Society Annual Meeting, San Francisco, CA 2013
  5. Endocrine Society Annual Meeting, Washington, D.C., 2009

Honor Society

Dr. King is married to Carter, an interventional cardiologist, and they have two daughters. In her free time, she enjoys spending time with her family and friends, playing tennis, enjoying the outdoors, and traveling. She is a member of and attends Park Cities Presbyterian Church.

Personal Interests

Dr. King is married to Carter, an interventional cardiologist, and they have two daughters. In her free time, she enjoys spending time with her family and friends, playing tennis, enjoying the outdoors, and traveling. She is a member of and attends Park Cities Presbyterian Church.

Specialty Procedures

A native Texan, Dr. Elizabeth King was born and raised in Houston. She graduated magna cum laude from Westfield High School and then attended The University of Texas at Austin, earning a bachelor of business administration in finance with honors in 1999. Dr. King graduated from the University of Texas Medical School at San Antonio in 2003 and stayed at the University of Texas Health Science Center at San Antonio (UTHSCSA) to pursue her postgraduate training in internal medicine where she also served as chief resident. She then completed her fellowship in endocrinology, diabetes, and metabolism at UTHSCSA in 2009. Dr. Elizabeth King served on the faculty at UTHSCSA for two years prior to relocating with her family to Dallas in 2011. From 2011-2014, she was a member of the faculty in the Department of Internal Medicine/Division of Endocrinology at the University of Texas Southwestern Medical School. She was pleased to join Endocrine Associates of Dallas in 2016.

Awards and Honors

  • 2009 Research Day Winner, Clinical Fellows, UTHSCSA Dept. of Medicine Research Day
  • 2009 Endocrine Society Travel Grant
  • 2007-2008 “Top 25” ACES Preceptor Award, awarded by UTHSCSA MS2 class
  • 2005 Gold Humanism Honor Society
  • 2005-2006 Teaching Award, awarded by UTHSCSA MS3 class
  • 2003-2004 Intern of the Year, UTHSCSA, awarded by internal medicine residents
  • 2003-2004 Compassion Award, UTHSCSA awarded by internal medicine residents
  • 2003-2004 Teaching Award, awarded by UTHSCSA MS3 class
  • 2003-2004 Excellence in Clinical Geriatrics, awarded by UTHSCSA geriatric faculty
  • 1999-2003 Houston Northwest Medical Center Auxiliary Scholarship for Students Entering Health, Health Science, and Medical Fields
  • 1995-1999 National Merit Scholarship Corporation Special Scholarship, Shell Oil Company

Research

The University of Texas Health Science Center at San Antonio, Department of Medicine/Hematology and Oncology

  • Translational research focused on genetic predisposition to pheochromocytoma and paraganglioma, Principal Investigator: Patricia Dahia, MD/PhD, Dates: 2007-2009

The University of Texas Southwestern Medical Center

  • Sub-investigator, “A phase III, multicenter, randomized, parallel-group study to assess the efficacy and safety of double-blind pasireotide LAR 40mg and pasireotide LAR 60mg versus open-label octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly,”, Novartis Pharmaceuticals, Dates: 2012-2014

Other Professional Activities

  • 2016-present Endocrinologist, Endocrine Associates of Dallas
  • 2011-2014 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Southwestern Medical Center
  • 2009-2011 Clinical Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Health Science Center at San Antonio
  • 2006-2011 Chief Resident/Clinical Instructor, Department of Medicine, The University of Texas Health, Science Center at San Antonio

Leadership Positions/Committee Work/Advisory Positions

  • Board Member, PTA, Hyer Elementary School
  • Advisor, Kappa Kappa Gamma, Gamma Phi Chapter

Service/Volunteer Work

2014-present Clinical Volunteer Assistant Professor, Department of Medicine/Endocrinology, The University of Texas Southwestern Medical Center

Biography

A native Texan, Dr. Elizabeth King was born and raised in Houston. She graduated magna cum laude from Westfield High School and then attended The University of Texas at Austin, earning a bachelor of business administration in finance with honors in 1999. Dr. King graduated from the University of Texas Medical School at San Antonio in 2003 and stayed at the University of Texas Health Science Center at San Antonio (UTHSCSA) to pursue her postgraduate training in internal medicine where she also served as chief resident. She then completed her fellowship in endocrinology, diabetes, and metabolism at UTHSCSA in 2009.

Dr. Elizabeth King served on the faculty at UTHSCSA for two years prior to relocating with her family to Dallas in 2011. From 2011-2014, she was a member of the faculty in the Department of Internal Medicine/Division of Endocrinology at the University of Texas Southwestern Medical School. She was pleased to join Endocrine Associates of Dallas in 2016.